- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent Adult Acute Myeloid Leukemia in New Zealand
Total 1179 results
-
University of RochesterCompletedAcute Myeloid LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterTerminatedAcute Myeloid Leukemia (AML)United States
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterTerminatedRecurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1United States
-
ImmunoGen, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedAcute Myeloid LeukemiaUnited States
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous Leukemia | Acute Promyelocytic LeukemiaUnited States
-
Chroma TherapeuticsUnknownAcute Myeloid LeukemiaUnited States
-
Yale UniversityBristol-Myers Squibb; National Cancer Institute (NCI)WithdrawnAcute Myeloid LeukemiaUnited States
-
University of RochesterCompletedAcute Myeloid LeukemiaUnited States
-
CSL LimitedCompletedAcute Myeloid Leukemia (AML)Australia
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic LeukemiaUnited States
-
Hoffmann-La RocheCompleted
-
Otsuka Australia Pharmaceutical Pty LtdRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Patient PreferenceNew Zealand, Australia
-
Columbia UniversityThe Leukemia and Lymphoma SocietyCompletedAcute Myeloid LeukemiaUnited States
-
Hetty CarrawayActive, not recruitingAcute Myeloid LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)TerminatedAcute Myeloid LeukemiaUnited States
-
SanofiTerminatedMyeloid LeukemiaUnited States, France, Spain
-
Bio-Path Holdings, Inc.RecruitingAcute Myeloid Leukemia (AML)United States
-
Daiichi Sankyo, Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States
-
Sumitomo Pharma America, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Weill Medical College of Cornell UniversityPfizer; Jazz PharmaceuticalsTerminatedAcute Myeloid LeukemiaUnited States
-
Boehringer IngelheimTerminatedLeukemia, Myeloid, AcuteUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Adult T Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Adult L1 Acute Lymphoblastic Leukemia | Adult L2 Acute Lymphoblastic...United States
-
CelgeneAbbVieCompletedLeukemia, Myeloid, AcuteUnited States, Australia
-
Cornerstone PharmaceuticalsTerminatedRelapsed/Refractory Acute Myeloid LeukemiaUnited States, Spain, Korea, Republic of, France, Australia, Belgium, Austria, Germany, Poland
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaUnited States, Canada
-
Weill Medical College of Cornell UniversityJazz PharmaceuticalsCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Relapsed Adult Acute Myeloid | Myelodysplastic Syndromes, Previously TreatedUnited States
-
BayerCompletedLeukemia, Myeloid, AcuteUnited States, Germany
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedAcute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Minimal Residual Disease | Therapy-Related Acute Myeloid Leukemia | Therapy-Related Myelodysplastic... and other conditionsUnited States
-
Pharmacyclics LLC.TerminatedAcute Myeloid Leukemia (AML)United States
-
CephalonCompletedAcute Myeloid LeukemiaUnited States, Canada, Australia, Germany, Israel, Italy, New Zealand, Poland, Romania, Russian Federation, Spain, Sweden, Ukraine
-
MedImmune LLCCompletedAcute Myeloid Leukemia | LeukemiaUnited States, Israel
-
SanofiRecruitingMyelodysplastic Syndromes | Acute Lymphocytic Leukaemia | Acute Myeloid Leukaemia Refractory | Blastic Plasmacytoid Dendritic Cell NeoplasiaNetherlands, France, United States, Australia, China
-
OrphAI TherapeuticsCompletedAcute Myeloid Leukemia | OncologyUnited States
-
Genta IncorporatedCompleted
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Polycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myelodysplastic/Myeloproliferative... and other conditionsUnited States
-
Aptose Biosciences Inc.Ohio State UniversityCompletedAcute Myeloid LeukemiaUnited States
-
Maxim PharmaceuticalsCompletedLeukemiaUnited States, France, Israel, Australia, Canada, Sweden, Finland, Germany, New Zealand, Denmark, Estonia, United Kingdom
-
Cellectis S.A.RecruitingRelapsed/Refractory Acute Myeloid LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterTakedaRecruiting
-
Actinium PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia | Leukemia, Myeloid, Acute | AML | Acute Myelogenous Leukemia | Bone Marrow Transplant | Myelogenous Leukemia, Acute | Myeloid Leukemia, Acute | Leukemia, Acute Myelogenous | Leukemia, Acute MyeloidUnited States, Canada
-
CelgeneRecruitingLeukemia, MyeloidUnited States, France, Canada
-
Caribou Biosciences, Inc.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedTherapy-Related Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | FLT3 Gene Mutation | Acute Promyelocytic Leukemia With PML-RARA | Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1United States
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma and other conditionsUnited States